Data is not available at this time.
MCI Onehealth Technologies Inc. operates as a hybrid healthcare provider in Canada, blending physical clinics with telehealth services to deliver accessible care. The company serves both individual patients and corporate clients, leveraging a network of 25 brick-and-mortar clinics alongside a virtual care platform. This dual approach positions MCI Onehealth to capitalize on the growing demand for flexible healthcare solutions, particularly in the post-pandemic era where telehealth adoption has surged. The company’s focus on corporate wellness programs and direct patient care diversifies its revenue streams while addressing gaps in Canada’s healthcare system. Despite competition from established providers and digital health startups, MCI Onehealth’s integrated model offers scalability and cost efficiencies. Its niche in employer-sponsored health services provides a stable client base, though reliance on corporate contracts introduces concentration risks. The healthcare facilities sector remains fragmented, but MCI Onehealth’s technology-enabled approach could differentiate it in a market increasingly prioritizing convenience and digital integration.
In FY 2022, MCI Onehealth reported revenue of CAD 53.2 million, reflecting its operational scale, but net losses widened to CAD 21.1 million, underscoring ongoing cost challenges. Negative operating cash flow (CAD 8.3 million) and modest capital expenditures (CAD 1.2 million) suggest reinvestment constraints. The diluted EPS of -CAD 0.42 highlights profitability hurdles despite revenue generation.
The company’s negative earnings and cash flow indicate limited near-term earnings power, with capital efficiency hampered by high operating costs relative to revenue. The absence of positive free cash flow restricts flexibility for growth initiatives or debt reduction, though telehealth scalability could improve margins over time.
MCI Onehealth’s financial health is strained, with CAD 1.4 million in cash against CAD 17.4 million in total debt, raising liquidity concerns. The weak cash position and persistent losses may necessitate further financing, though the lack of dividend obligations preserves capital for operational needs.
Growth hinges on expanding telehealth adoption and corporate partnerships, but FY 2022’s losses signal execution risks. The company does not pay dividends, aligning with its focus on reinvestment, though profitability must improve to sustain expansion.
With a market cap of CAD 49.4 million and negative earnings, valuation relies on future growth potential in digital health. The negative beta (-0.59) suggests atypical market correlation, possibly reflecting speculative investor sentiment.
MCI Onehealth’s hybrid model and corporate focus provide differentiation, but profitability remains critical. Success depends on scaling virtual care efficiently and managing debt. Sector tailwinds support long-term opportunities, though near-term execution risks persist.
Company filings, TSX disclosures
show cash flow forecast
| Fiscal year | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |